A detailed history of Asset Management One Co., Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 239,392 shares of EW stock, worth $16.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
239,392
Previous 237,204 0.92%
Holding current value
$16.2 Million
Previous $21.9 Million 27.9%
% of portfolio
0.06%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$59.7 - $93.78 $130,623 - $205,190
2,188 Added 0.92%
239,392 $15.8 Million
Q2 2024

Jul 18, 2024

SELL
$84.3 - $94.31 $600,468 - $671,770
-7,123 Reduced 2.92%
237,204 $21.9 Million
Q1 2024

May 02, 2024

SELL
$72.54 - $95.56 $3.34 Million - $4.4 Million
-46,075 Reduced 15.87%
244,327 $23.3 Million
Q4 2023

Jan 24, 2024

SELL
$61.71 - $77.76 $2.03 Million - $2.55 Million
-32,822 Reduced 10.15%
290,402 $22.1 Million
Q3 2023

Oct 19, 2023

BUY
$69.28 - $93.38 $112,372 - $151,462
1,622 Added 0.5%
323,224 $22.4 Million
Q2 2023

Jul 31, 2023

BUY
$81.41 - $94.33 $1.16 Million - $1.34 Million
14,236 Added 4.63%
321,602 $30.3 Million
Q1 2023

Apr 25, 2023

BUY
$74.26 - $84.51 $1.15 Million - $1.31 Million
15,512 Added 5.31%
307,366 $25.4 Million
Q4 2022

Feb 06, 2023

SELL
$68.3 - $87.44 $1.13 Million - $1.44 Million
-16,522 Reduced 5.36%
291,854 $21.8 Million
Q3 2022

Nov 04, 2022

SELL
$82.37 - $107.29 $40,526 - $52,786
-492 Reduced 0.16%
308,376 $25.5 Million
Q2 2022

Jul 29, 2022

SELL
$86.5 - $128.27 $368,663 - $546,686
-4,262 Reduced 1.36%
308,868 $29.4 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $2.87 Million - $3.62 Million
-28,177 Reduced 8.26%
313,130 $36.9 Million
Q4 2021

Feb 09, 2022

BUY
$106.37 - $130.68 $1.34 Million - $1.65 Million
12,602 Added 3.83%
341,307 $44.6 Million
Q3 2021

Nov 02, 2021

BUY
$102.91 - $122.75 $64,318 - $76,718
625 Added 0.19%
328,705 $37.2 Million
Q2 2021

Aug 03, 2021

SELL
$83.84 - $104.76 $5.05 Million - $6.3 Million
-60,185 Reduced 15.5%
328,080 $34 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $1.45 Million - $1.67 Million
-18,470 Reduced 4.54%
388,265 $32.5 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $1.88 Million - $2.39 Million
26,250 Added 6.9%
406,735 $36.6 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $344,751 - $448,654
5,131 Added 1.37%
380,485 $30.4 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $13.5 Million - $18 Million
234,450 Added 166.39%
375,354 $25.9 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $387,834 - $599,400
7,400 Added 5.54%
140,904 $26.6 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $292,105 - $334,434
-4,074 Reduced 2.96%
133,504 $31.1 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $289,900 - $355,275
4,710 Added 3.54%
137,578 $30.3 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $1.09 Million - $1.26 Million
19,536 Added 17.24%
132,868 $24.5 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $11.8 Million - $15.7 Million
-245,639 Reduced 68.43%
113,332 $21.7 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $61,586 - $75,559
1,327 Added 0.37%
358,971 $54.9 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $289,509 - $367,620
6,335 Added 1.8%
357,644 $62.2 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $530,115 - $640,634
12,488 Added 3.69%
351,309 $51.2 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $227,937 - $290,821
6,129 Added 1.84%
338,821 $47.3 Million
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $27,437 - $31,984
812 Added 0.24%
332,692 $37.5 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $74,938 - $80,183
2,065 Added 0.63%
331,880 $36.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
329,815
329,815 $39 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.